IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

作者：Fabrice Barlési, Makoto Nishio, Manuel Cobo, Nicola Steele, V.V. Paramonov, B. Parente, Rachel Dear, H. Bérard, Nir Peled, Lasika Seneviratne, Editta Baldini, Satoshi Watanabe, Keiko Goto, Diana Mendus, Hina Patel, Yu Deng, Marcin Kowanetz, Tien Hoang, Wei‐Hung Lin, Vassiliki A. Papadimitrakopoulou · 发表于：Annals of Oncology · 年份：2018 · DOI：10.1093/annonc/mdy424.066 · 被引用次数：49 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Lung Cancer Diagnosis and Treatment